Drug Trial Radar · NCT01956123
Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2
Last checked: Nov 19, 2026Latest source record: Sep 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
513
Actual
Start
Mar 26, 2014
Primary completion
May 2015
Study completion Jan 3, 2017
Sponsor
- Lead sponsor
- Ferring PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial investigates the immunogenicity of FE 999049 in repeated cycles.
Conditions
- Infertility
Interventions
Follitropin Delta (FE 999049)Drug
Follitropin Alfa (GONAL-F)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion (Percentage) of Subjects With Treatment-induced Anti-Follicle-Stimulating Hormone (FSH) Antibodies After up to Two Repeated Controlled Ovarian Stimulation CyclesTime frame: Stimulation day 1, 7-10 days after last FE 999049 or GONAL-F dose and 21-28 days after last FE 999049 or GONAL-F dose
Locations
13 sites in 11 countries. Site status is shown where the registry gives one.
UZ Brussel (there may be other sites in this country)
Brussels, Belgium
Fertilitat and PUC-RS (there may be other sites in this country)
Porto Alegre, Brazil
Pacific Centre for Reproductive Medicine
Burnaby, British Columbia, Canada
Olive Fertility Centre
Vancouver, British Columbia, Canada
Ottawa Fertility Centre
Ottawa, Ontario, Canada
IVF CUBE SE (there may be other sites in this country)
Prague, Czechia
Rigshospitalet Fertilitetsklinikken (there may be other sites in this country)
Copenhagen, Denmark
Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre (there may be other sites in this country)
Lille, France
Centro Natalità San Raffaele (there may be other sites in this country)
Milan, Italy
The nOvum Clinic (there may be other sites in this country)
Warsaw, Poland
IVF & Reproductive Genetics Center (there may be other sites in this country)
Moscow, Russia
IVI Sevilla (there may be other sites in this country)
Seville, Spain
Glasgow Centre for Reproductive Medicine Ltd. (there may be other sites in this country)
Glasgow, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.